Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
Metrion is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme New service with GLP certification furt
Global Access Diagnostics (GADx) reintroduces IT-Leish, the rapid diagnostic test for visceral leishmaniasis
London, UK - Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, announces the launch of IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL).
Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification
New automated kit overcomes major bottleneck in peptide production, providing optimized simultaneous workflows
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M.
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
H.E.L Group signs agreement with Indian Institute of Technology (IIT) Kanpur in national initiative for sustainable energy
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it has signed an agreement with the Indian Institute of Technology Kanpur (IIT Kanpur), a prestigious Indian academic institution kickstarting scientific and technological research. The collaboration is part of a national initiative in sustainable…
Arrayjet announces collaboration with Chemspace to augment its small molecule microarray services for drug discovery
Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for…
Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult
Metrion Biosciences expands senior leadership team with appointments of Dr Robert Kirby as COO and Dr Edward Stevens as CSO
Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations
FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with Clinical Decision-making in IVF
SANTA ANA, California - FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announces the addition of the Life Whisperer Genetics module to its Life Whisperer software package (launched in 2021)1, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF).
Avacta announces successful completion of fifth dose escalation in AVA6000 Phase 1 clinical study
Very positive safety profile of AVA6000 continues to be observed in the fifth cohort <
Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer
Key executive appointment supports strategic operational delivery of the Company’s product and partnership programs
H.E.L Group expands into new purpose-designed facilities
· Investment in new global headquarters forms part of ongoing growth plans
Avacta appoints Shaun Chilton as Non-executive Director
Appointment brings additional, significant commercial and corporate development experience to the Board
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US operations
Appointment supports growth of Metrion’s pre-clinical ion channel contract research and safety pharmacology services.
H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development
Automated parallel bioreactor offering updated with increased capabilities for multi-parameter process development BioXplorer systems are modular and high
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that a second milestone equity payment has been triggered resulting in an in
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC)
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC) to characterize patients across hard-to-diagnose mental health conditions.
Avacta acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics.
Cellular Origins launches Constellation, its configurable robotic platform to enable scalable manufacture of advanced therapies
Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold respectively
Closed Loop Medicine and Pharmanovia enter a co-development partnership for precision medicine combination therapeutics
Pharmanovia’s leading medicine brands to be combined with Closed Loop Medicine’s technology to provide dose optimized personalized therapies Global (ex-US) co-development and commercialization
H.E.L Group makes senior appointments as it continues to scale globally
Hasan Hallaq, PhD appointed as European Sales Director, Victoria Ordsmith joins as Director of Marketing and Sarennah Longworth-Cook promoted Director of People Appointments
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), announces collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together process development expertise, tools and technologies for scalable CGT manufacturing. The partnership aims to automate…
Global Access Diagnostics (GADx) welcomes new leadership
Global Access Diagnostics (GADx) announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and
Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples